# A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)

> **NCT01728584** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 127 (actual)

## Conditions studied

- Gallbladder Disease

## Interventions

- **DRUG:** Rocuronium
- **OTHER:** Insufflation
- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT01728584
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-28
- **Primary completion:** 2014-04-29
- **Final completion:** 2014-04-29
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2018-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728584, "A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01728584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*